openPR Logo
Press release

The antibody contract manufacturing market is projected to reach USD 17 billion by 2030, growing at an annualized rate of 12%, claims Roots Analysis

11-24-2020 05:57 AM CET | Health & Medicine

Press release from: Roots Analysis

The antibody contract manufacturing market is projected

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone

Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.

Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production. Further, prevalent trends suggest that sponsor companies are likely to continue relying on contract service providers for various aspects of antibody-based product development and manufacturing.

To order this 285+ page report, which features 100+ figures and 110+ tables, please visit this link https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html or email sales@rootsanalysis.com

Key Market Insights

Over 100 CMOs presently claim to offer manufacturing services for antibodies
The antibody contract manufacturing market is currently dominated by the presence of small and mid-sized companies, which represent 70% of the industry stakeholders. It is also worth highlighting that more than 55% of CMOs claim to have the capabilities to manufacture antibodies across all scales of operation (preclinical, clinical and commercial).

More than 90% service providers are focused on the production of monoclonal antibodies
However, players based in Asia are now increasingly focusing on the development of bispecific antibodies for therapeutic use. It worth highlighting that close to 20% of the CMOs engaged in this domain claim to offer manufacturing services for both bispecific antibodies and antibody fragments.

Europe has emerged as a key manufacturing hub for antibody-based products
More than 120 manufacturing facilities have been established by various players, worldwide; of these, 40% are in Europe. Additionally, 40% of the total installed capacity is in Europe, followed by Asia. Some of the prominent regions in Asia include (in decreasing order of number of manufacturing facilities) China, South Korea, India, Japan and Taiwan.

More than 90 partnership agreements have been inked between 2013 and 2019
Majority of these agreements were focused on manufacturing of various types of antibodies. Other popular types of collaboration models include process development and manufacturing agreements (22%), product development and manufacturing agreements (10%) and licensing agreements (7%).

For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html or email sales@rootsanalysis.com

Multiple expansion initiatives were undertaken by CMOs between 2017 and 2019
More than 50% of such initiatives were reported to be focused on the expansion of manufacturing facilities, followed by building new facilities (38%). It is worth noting that close to 50% of the total number of expansion initiatives were undertaken in Europe, of which, 25% were in the UK.

Demand for therapeutic antibodies is anticipated to grow at a CAGR of 10%, during 2020-2025
Given the fact that there are a number of antibody-based products in the market, the commercial demand for antibodies is significantly higher than the clinical demand. Across the three major global regions, North America represent over half of the overall global manufacturing demand for antibodies.

North America and Europe are anticipated to capture over 70% of the market share by 2030
However, the market in the Asia is anticipated to grow at a relatively faster rate. Further, presently, more than 90% of the antibodies are being developed using mammalian expression systems, and this trend is unlikely to change significantly in short to mid-term.

To request a sample copy / brochure of this report, please visit this link https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html or email sales@rootsanalysis.com

Key Questions Answered
Who are the leading CMOs engaged in the production of antibody-based therapeutics?
What kind of partnership models are commonly adopted by stakeholders in this industry?
What is the annual clinical and commercial demand for antibody-based products?
What is the current installed capacity for manufacturing of antibodies?
What are the various expansion initiatives undertaken by antibody CMOs?
How is the current and future market opportunity likely to be distributed across key market segments?

The USD 17 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed across the following segments:
Type of Antibodies
Monoclonal Antibodies
Bispecific Antibodies
ADCs
Others

Company Size
Small
Mid-sized
Large / Very Large

Scale of Operation
Preclinical / Clinical
Commercial

Type of expression system used
Mammalian
Microbial

Key geographical regions
North America
Europe
Asia and RoW

For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html or email sales@rootsanalysis.com

The report features inputs from eminent industry stakeholders, according to whom antibody therapeutics developers are increasingly outsourcing their manufacturing operations owing to complex nature of the overall process, as well as the high investments associated with setting-up in-house expertise. The report includes detailed transcripts of discussions held with the following experts:
Dietmar Katinger (Chief Executive Officer, Polymun Scientific)
David C Cunningham (Director, Corporate Development, Goodwin Biotechnology)
Claire Otjes (Marketing Manager, Batavia Biosciences)

The research covers profiles of key players that offer manufacturing services for antibodies, featuring a company overview, information on their respective service portfolios, manufacturing facilities and capabilities, and an informed future outlook.
AGC Biologics
Aldevron
AMRI
Boehringer Ingelheim BioXcellence
Emergent BioSolutions
Eurofins CDMO
FUJIFILM Diosynth Biotechnologies
KBI Biopharma
Lonza
Nitto Avecia Pharma Services
Novasep
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific

For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html or email sales@rootsanalysis.com

You may also be interested in the following titles:
1. Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030
2. Antibody Drug Conjugates (ADCs) - Linker and Conjugation Technologies Market, 2019-2030
3. Antibody Drug Conjugates Market (5th Edition), 2019-2030

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The antibody contract manufacturing market is projected to reach USD 17 billion by 2030, growing at an annualized rate of 12%, claims Roots Analysis here

News-ID: 2193897 • Views:

More Releases from Roots Analysis

The Agricultural Biologicals Market Size Worth over USD 40 Billion in 2035 | Roo …
Global Agricultural Biologicals Market Overview The agricultural biologicals market is a rapidly growing and dynamic industry that is poised to grow at a CAGR of 9.98% in the forecast period 2023-2035. The growth in the agricultural biologicals market size over the next decade is likely to be the result of a rise in the demand for organic food coupled with the growing focus on sustainable agriculture. Agricultural biologics include a vast
The Lab Automation Market is anticipated to grow at a CAGR of around 15% by 2035, claims Roots Analysis
The Lab Automation Market is anticipated to grow at a CAGR of around 15% by 2035 …
Owing to the advanced features and cost-saving potential of automation, stakeholders in the healthcare industry are adopting lab automation systems in order to get precise results and reduce deviations occurring due to manual handling Roots Analysis has announced the addition of "Lab Automation Market, 2023-2035" report to its list of offerings. The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology
The gene therapy market is projected to be worth USD 17.3 billion in 2035, growi …
Given the potential of gene therapies to permanently cure a diverse array of clinical conditions at the genetic level, the current pipeline is rapidly growing; a number of such therapies are currently being evaluated in late stages of development London Roots Analysis has announced the addition of "Gene Therapy Market" report to its list of offerings. Post the emergence of blockbuster gene therapies, such as ZOLGENSMA® (for spinal muscular atrophy type
The companion diagnostics development services market, is anticipated to grow at a CAGR of over 10%, till 2035, claims Roots Analysis
The companion diagnostics development services market, is anticipated to grow at …
Roots Analysis has announced the addition of "Companion Diagnostics Development Services Market (2nd Edition), 2022-2035" report to its list of offerings. The growing pipeline of patient-centric targeted therapies has led to a surge in demand for companion diagnostics; these tests are known to improve the success rates of late-stage trials by almost three-fold. The development and approval of these FDA classified high-risk devices requires multidisciplinary expertise and an established network of

All 5 Releases


More Releases for CMOs

CMOS and sCMOS Image Sensors CMOS and sCMOS Image Sensors
The latest CMOS and sCMOS Image Sensors market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thorough analysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. Request a sample on this latest research report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5096977 Top Key Players are covered in this report:
Global In-vehicle Camera CMOS Market
Global In-vehicle Camera CMOS Market Overview: The latest report published by QY Research demonstrates that the global In-vehicle Camera CMOS market will showcase a steady CAGR in the coming years. The research report includes a thorough analysis of the market drivers, restraints, threats, and opportunities. It addresses the lucrative investment options for the players in the coming years. Analysts have offered market estimates at a global and a regional level. The research
Global CMOS Sensor Market Insights, Forecast
The CMOS Sensor market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for CMOS Sensor Get sample copy of the report: https://www.marketdensity.com/contact?ref=Sample&reportid=49874 Table of Contents: Table of Contents 1 Study Coverage 1.1
CCD And CMOS Sensors Market Report 2018: Segmentation by Type (CMOS sensor, CCD …
Global CCD And CMOS Sensors market research report provides company profile for Coherent, E2V Technologies Plc, Galaxycore Inc., Infineon Technologies Ag, M2 Optics Inc., Agilent Technologies Inc., Alcatel-Lucent (Nokia Group), Broadcom Ltd., Cmosis N.V. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,
CMOS Image Sensor Market Report 2018: Segmentation by Product (Front-illuminated …
Global CMOS Image Sensor market research report provides company profile for ST, Nikon, PixelPlus, Pixart, SiliconFile, GalaxyCore, Sony, Samsung, OmniVision, Canon, On Semi (Aptina), Toshiba and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
CMOS Camera Lens Market Outlook 2022:Analysis By Type(Ordinary CMOS Camera Lens, …
CMOS Camera Lens Market Overview Brief Description:Miniature CCD/CMOS lenses are designed to provide optimal image performance for a variety of applications using CCD/CMOS imaging sensors. Typical consumer product applications include: digital cameras, PC cameras, cell phone and PDA cameras, security cameras, etc The Global CMOS Camera Lens Market skilled Survey Report scrutinizes the prevailing state of affairs and also the destiny growth potentialities of the business. It covers the market place